AC
Insider selling
Adam Crystal sold $604K of Tango Therapeutics, Inc. (TNGX) stock
Adam Crystal, President, R&D of Tango Therapeutics, Inc. (TNGX), sold 27,000 shares of TNGX stock worth $604K, per an SEC Form 4 filed Sep 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 1, 2026, 2 days before it was made public.
TNGX has moved +14.2% since the trade date, from $22.35 to $25.53 (Sep 22, 2026 close).
- Traded
- Sep 1, 2026
- Disclosed
- Sep 3, 2026
- Filing delay
- 2 days
- Price since
- +14.2%
- Role
- President, R&D
- Source
- SEC Form 4
More TNGX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.